Therese Lloyd is a Principal Data Analyst in the Improvement Analytics Unit.
Therese joined the Health Foundation in October 2014 and worked in the Data Analytics and Economics teams before joining the Improvement Analytics Unit. Prior to joining the Health Foundation, Therese worked at Prostate Cancer UK, where she instigated and conducted analyses on the lifetime risk of prostate cancer in different ethnic groups.
Previous to this, she co-founded Zendegii, a company that creates healthy foods and beverages and provides information to other businesses around nutrition and product development.
Preceding this, Therese worked in clinical trials as a statistician for six years. She worked on a wide range of projects across various therapeutic areas, including oncology, cardiology and immunology. She has experience of phase II, III and IV randomised clinical trials.
Therese has a Bachelor’s and a Master’s degree in Statistics from Lund University, Sweden.
Lloyd T, Conti S, Santos F, Steventon A, Effect on secondary care of providing enhanced support to residential and nursing home residents: a subgroup analysis of a retrospective matched cohort study. BMJ Quality & Safety 2019; 28: 534-546.
Lloyd T, Deeny S, and Steventon A. Weekend admissions may be associated with poorer recording of long-term comorbidities: a prospective study of emergency admissions using administrative data, BMC Health Serv Res. 2018; 18: 863.
Barker I, Lloyd T, Steventon A. Effect of a national requirement to introduce named accountable general practitioners for patients aged 75 or older in England: regression discontinuity analysis of general practice utilisation and continuity of care. BMJ Open 2016;6:e011422 doi:10.1136/bmjopen-2016-011422
Lloyd T, Steventon A. Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change. International Journal of Integrated Care. 2016;16(1):6.
Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Medicine 2015; 13:171.